Note: MCSP ended in December 2019. No new content is added to this site.

Photo courtesy of Mubeen Siddiqui/MCSP.

September 25th Technical Consultation: Expanding Contraceptive Method Choice

Posted October 8, 2019

On September 25th, the Long-acting and Reversible Contraceptives and Permanent Methods Community of Practice (CoP) became the Method Choice CoP — and held a technical consultation meeting to acknowledge the transition. Meeting attendees, gathered at the Human Rights Campaign offices in D.C. and viewing remotely, explored new data on method mix and choice, and learned from country experiences about what it takes to operationalize an environment where all individuals are freely able to choose a contraceptive method best suited to their lifestyle and reproductive desires.

Participants developed an understanding of what the data tell us about contraceptive method choice, where it is inadequate for doing so, and what opportunities exist for understanding method choice better. Global experts discussed the process of — and lessons from — introducing a new method and how it affects contraceptive choice at the country level. Those attending also recognized, extracted and reflected on major arguments in the pursuit of balancing efforts between investment in new contraceptive method development with making better use of the contraceptive methods already available. Participants left able to identify and recommend key priority technical areas of focus for the new Method Choice CoP.

To watch a recording of the event, click here.

To read the meeting report, click here.

Click on speaker names below to download their presentations:

Welcome and Opening

Data panel: What can data on contraceptive method availability and mix tell us about method choice?



Country panel: What does it take to introduce a new method and how does it affect contraceptive choice at country level?


  • Martyn Smith, Managing Director, FP2020


Debate: Do we need new contraceptive methods to ensure more choice?


  • John W Townsend, Director, Country Strategy, Population Council


  • Laneta Dorflinger, Distinguished Scientist and Director, FHI 360
  • Roy Jacobstein, Global Technical Lead for FP, Intrahealth

Discussion: Shaping the Method Choice CoP Together



  • Anne Pfitzer, Family Planning Technical Team Lead, MCSP
  • Trish MacDonald, Senior Technical Advisor, USAID
Maternal and Child Survival Program